The use of acellular dermal matrix in immediate two-stage tissue expander breast reconstruction

Katie E. Weichman, Stelios C. Wilson, Andrew L. Weinstein, Alexes Hazen, Jamie P. Levine, Mihye Choi, Nolan S. Karp

Research output: Contribution to journalArticle

92 Citations (Scopus)

Abstract

Background:: Acellular dermal matrix is commonly used in implant-based breast reconstruction to allow for quicker tissue expansion with better coverage and definition of the lower pole of the breast. This study was performed to analyze complications associated with its use in immediate two-stage, implant-based breast reconstruction and to subsequently develop guidelines for its use. Methods:: A retrospective analysis of 628 consecutive immediate two-stage tissue expander breast reconstructions at a single institution over a 3-year period was conducted. The reconstructions were divided into two groups: reconstruction with acellular dermal matrix and reconstruction without it. Demographic information, patient characteristics, surface area of acellular dermal matrix, and complications were analyzed and compared. Results:: A total of 407 patients underwent 628 immediate two-stage, implant-based breast reconstructions; 442 reconstructions (70.3 percent) used acellular dermal matrix and 186 (29.6 percent) did not. The groups had similar patient characteristics; however, major complications were significantly increased in the acellular dermal matrix group (15.3 versus 5.4 percent; p = 0.001). These complications included infection requiring intravenous antibiotics (8.6 versus 2.7 percent; p = 0.001), flap necrosis requiring excision (6.7 versus 2.7 percent; p = 0.015), and explantation of the tissue expander (7.7 versus 2.7 percent; p = 0.004). Conclusions:: Use of acellular dermal matrix in immediate two-stage, implant-based breast cancer reconstruction is associated with a significant increase in major complications. Therefore, it should only be used in specific patients and in minimal amounts. Indications for its use include single-stage permanent implant reconstruction and inadequate local muscle coverage of the tissue expander.

Original languageEnglish (US)
Pages (from-to)1049-1058
Number of pages10
JournalPlastic and Reconstructive Surgery
Volume129
Issue number5
DOIs
StatePublished - May 2012
Externally publishedYes

Fingerprint

Acellular Dermis
Tissue Expansion Devices
Mammaplasty
Tissue Expansion
Breast
Necrosis
Demography
Guidelines
Breast Neoplasms
Anti-Bacterial Agents
Muscles
Infection

ASJC Scopus subject areas

  • Surgery

Cite this

The use of acellular dermal matrix in immediate two-stage tissue expander breast reconstruction. / Weichman, Katie E.; Wilson, Stelios C.; Weinstein, Andrew L.; Hazen, Alexes; Levine, Jamie P.; Choi, Mihye; Karp, Nolan S.

In: Plastic and Reconstructive Surgery, Vol. 129, No. 5, 05.2012, p. 1049-1058.

Research output: Contribution to journalArticle

Weichman, Katie E. ; Wilson, Stelios C. ; Weinstein, Andrew L. ; Hazen, Alexes ; Levine, Jamie P. ; Choi, Mihye ; Karp, Nolan S. / The use of acellular dermal matrix in immediate two-stage tissue expander breast reconstruction. In: Plastic and Reconstructive Surgery. 2012 ; Vol. 129, No. 5. pp. 1049-1058.
@article{5a6f3fe91c544b7ebc0037d464a7f308,
title = "The use of acellular dermal matrix in immediate two-stage tissue expander breast reconstruction",
abstract = "Background:: Acellular dermal matrix is commonly used in implant-based breast reconstruction to allow for quicker tissue expansion with better coverage and definition of the lower pole of the breast. This study was performed to analyze complications associated with its use in immediate two-stage, implant-based breast reconstruction and to subsequently develop guidelines for its use. Methods:: A retrospective analysis of 628 consecutive immediate two-stage tissue expander breast reconstructions at a single institution over a 3-year period was conducted. The reconstructions were divided into two groups: reconstruction with acellular dermal matrix and reconstruction without it. Demographic information, patient characteristics, surface area of acellular dermal matrix, and complications were analyzed and compared. Results:: A total of 407 patients underwent 628 immediate two-stage, implant-based breast reconstructions; 442 reconstructions (70.3 percent) used acellular dermal matrix and 186 (29.6 percent) did not. The groups had similar patient characteristics; however, major complications were significantly increased in the acellular dermal matrix group (15.3 versus 5.4 percent; p = 0.001). These complications included infection requiring intravenous antibiotics (8.6 versus 2.7 percent; p = 0.001), flap necrosis requiring excision (6.7 versus 2.7 percent; p = 0.015), and explantation of the tissue expander (7.7 versus 2.7 percent; p = 0.004). Conclusions:: Use of acellular dermal matrix in immediate two-stage, implant-based breast cancer reconstruction is associated with a significant increase in major complications. Therefore, it should only be used in specific patients and in minimal amounts. Indications for its use include single-stage permanent implant reconstruction and inadequate local muscle coverage of the tissue expander.",
author = "Weichman, {Katie E.} and Wilson, {Stelios C.} and Weinstein, {Andrew L.} and Alexes Hazen and Levine, {Jamie P.} and Mihye Choi and Karp, {Nolan S.}",
year = "2012",
month = "5",
doi = "10.1097/PRS.0b013e31824a2acb",
language = "English (US)",
volume = "129",
pages = "1049--1058",
journal = "Plastic and Reconstructive Surgery",
issn = "0032-1052",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - The use of acellular dermal matrix in immediate two-stage tissue expander breast reconstruction

AU - Weichman, Katie E.

AU - Wilson, Stelios C.

AU - Weinstein, Andrew L.

AU - Hazen, Alexes

AU - Levine, Jamie P.

AU - Choi, Mihye

AU - Karp, Nolan S.

PY - 2012/5

Y1 - 2012/5

N2 - Background:: Acellular dermal matrix is commonly used in implant-based breast reconstruction to allow for quicker tissue expansion with better coverage and definition of the lower pole of the breast. This study was performed to analyze complications associated with its use in immediate two-stage, implant-based breast reconstruction and to subsequently develop guidelines for its use. Methods:: A retrospective analysis of 628 consecutive immediate two-stage tissue expander breast reconstructions at a single institution over a 3-year period was conducted. The reconstructions were divided into two groups: reconstruction with acellular dermal matrix and reconstruction without it. Demographic information, patient characteristics, surface area of acellular dermal matrix, and complications were analyzed and compared. Results:: A total of 407 patients underwent 628 immediate two-stage, implant-based breast reconstructions; 442 reconstructions (70.3 percent) used acellular dermal matrix and 186 (29.6 percent) did not. The groups had similar patient characteristics; however, major complications were significantly increased in the acellular dermal matrix group (15.3 versus 5.4 percent; p = 0.001). These complications included infection requiring intravenous antibiotics (8.6 versus 2.7 percent; p = 0.001), flap necrosis requiring excision (6.7 versus 2.7 percent; p = 0.015), and explantation of the tissue expander (7.7 versus 2.7 percent; p = 0.004). Conclusions:: Use of acellular dermal matrix in immediate two-stage, implant-based breast cancer reconstruction is associated with a significant increase in major complications. Therefore, it should only be used in specific patients and in minimal amounts. Indications for its use include single-stage permanent implant reconstruction and inadequate local muscle coverage of the tissue expander.

AB - Background:: Acellular dermal matrix is commonly used in implant-based breast reconstruction to allow for quicker tissue expansion with better coverage and definition of the lower pole of the breast. This study was performed to analyze complications associated with its use in immediate two-stage, implant-based breast reconstruction and to subsequently develop guidelines for its use. Methods:: A retrospective analysis of 628 consecutive immediate two-stage tissue expander breast reconstructions at a single institution over a 3-year period was conducted. The reconstructions were divided into two groups: reconstruction with acellular dermal matrix and reconstruction without it. Demographic information, patient characteristics, surface area of acellular dermal matrix, and complications were analyzed and compared. Results:: A total of 407 patients underwent 628 immediate two-stage, implant-based breast reconstructions; 442 reconstructions (70.3 percent) used acellular dermal matrix and 186 (29.6 percent) did not. The groups had similar patient characteristics; however, major complications were significantly increased in the acellular dermal matrix group (15.3 versus 5.4 percent; p = 0.001). These complications included infection requiring intravenous antibiotics (8.6 versus 2.7 percent; p = 0.001), flap necrosis requiring excision (6.7 versus 2.7 percent; p = 0.015), and explantation of the tissue expander (7.7 versus 2.7 percent; p = 0.004). Conclusions:: Use of acellular dermal matrix in immediate two-stage, implant-based breast cancer reconstruction is associated with a significant increase in major complications. Therefore, it should only be used in specific patients and in minimal amounts. Indications for its use include single-stage permanent implant reconstruction and inadequate local muscle coverage of the tissue expander.

UR - http://www.scopus.com/inward/record.url?scp=84860723536&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860723536&partnerID=8YFLogxK

U2 - 10.1097/PRS.0b013e31824a2acb

DO - 10.1097/PRS.0b013e31824a2acb

M3 - Article

C2 - 22544088

AN - SCOPUS:84860723536

VL - 129

SP - 1049

EP - 1058

JO - Plastic and Reconstructive Surgery

JF - Plastic and Reconstructive Surgery

SN - 0032-1052

IS - 5

ER -